FDA’s lab developed test rule could be first check on agency’s power post-Chevron
The Supreme Court’s decision to overturn the Chevron doctrine would make it easier to challenge agency regulations, such as the LDT final rule.
The Supreme Court’s decision to overturn the Chevron doctrine would make it easier to challenge agency regulations, such as the LDT final rule.
The findings are a “big deal,” according to one expert, as CVS’ health insurer didn’t follow some “major requirements that are essential to ensuring that the IDR process runs smoothly.”
HHS officials Micky Tripathi and Troy Tazbaz resigned from their roles as non-voting members of the Coalition for Health AI, an industry group working to create standards for artificial intelligence in healthcare.
More than 60 Medicare Advantage health plans from 40 insurers have received a higher star rating for 2024, according to a Healthcare Dive analysis.
The sweeping payment rule also solidifies continuous eligibility requirements for children in Medicaid and CHIP, and holds hospitals to higher obstetric care delivery standards in a bid to improve maternal mortality.
On Tuesday, regulators updated the public on their almost three-year-old inquiry into PBMs’ anticompetitive business practices. The report is not positive for the drug middlemen, which immediately criticized it as one-sided.
The judge ruled the HHS had overstepped in applying an employment law decision to healthcare, a decision some experts say could occur more frequently after the Chevron doctrine was overturned.
Laizer Kornwasser was terminated without cause after his position was eliminated. The executive change comes after Teladoc named a new CEO last month.
Healthcare associations say insurers and vendors need to be more clearly included in the regulation, citing the impact of the Change Healthcare cyberattack.
Judge Ada E. Brown held that the agency violated the Administrative Procedural Act and exceeded its statutory authority.